BIOMAB, INC.
Update:2025/12/03
Industries
Main Industry
Health Care
Main Product/Service
1. CTC Detection System
2. NK Cell Expansion Kit
3. MSC Expansion Kit
4. Anti-EpCAM Monoclonal Antibody
5. EPCAM-FITC
2. NK Cell Expansion Kit
3. MSC Expansion Kit
4. Anti-EpCAM Monoclonal Antibody
5. EPCAM-FITC
Founded Year
2012
Unified Business No.
53775208
Status
Active
Number of Employees
0
Total Paid-in
Capital
50,171,930 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
BioMab discovers and develops cutting-edge immune-based diagnostics and therapeutics to enable healthcare to provide patients with personalized care. Their services are immune-based diagnostics, biotech, antibody services, and cancer diagnostics.